Adventures in the pharmacological analysis of P2 receptors

Journal of the Autonomic Nervous System

Volumn 81, Issue 1-3, 2000, Pages 178-186

  Fagura, Malbinder S ^a   Jarvis, Gavin E ^b   Dougall, Iain G ^a   Leff, Paul ^a  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adenosine 3' phosphate, 5' Phosphate; Adenosine 5' diphosphate; Adenosine 5' triphosphate; Agonists; Antagonists; AR C67085; AR C67156; Desensitisation; Ecto nucleotidases; Non equilibrium; P2 receptors; Pharmacological classification; Platelets; Suramin

Indexed keywords

PURINE P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE;

DRUG DESIGN; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG STABILITY; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0034601264     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(00)00136-3     Document Type: Article

References (26)

1. Bianchi B.R., Lynch K.J., Touma E., Niforatos W., Burgard E.C., Alexander K.M., Park H.S., Yu H., Metzger R., Kowaluk E., Jarvis M.F., van-Biesen T. Pharmacological characterisation of recombinant human and rat P2X receptor subtypes. Eur. J. Pharmacol. 376:1999;127-138.
2. 1 receptor. Mol. Pharmacol. 50:1996;1323-1329.
3. Burnstock G. Purinergic nerves. Pharmacol. Rev. 24:1972;509-581.
4. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptors? Gen. Pharmacol. 16:(5):1985;433-440.
5. Collo G., North R.A., Kawashima E., Merlo-Pich E., Neidhart S., Suprenant A., Buell G. Cloning of P2X5 and P2X6 receptors and distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci. 16:(8):1996;2495-2507.
6. Crack B.E., Beukers M.W., McKechnie K.C.W., Ijzerman A.P., Leff P. Pharmacological analysis of ecto ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X purinoceptor ligands. Br. J. Pharmacol. 113:1994;1432-1438.
7. Crack B.E., Pollard C.E., Beukers M.W., Roberts S.M., Hunt S.F., Ingall A.H., McKechnie K.C.W., Ijzerman A.P., Leff P. Pharmacological and biochemical analysis of FPL67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol. 114:1995;475-481.
8. ADP receptors. Br. J. Pharmacol. 124:1998;157-164.
9. Furchgott R.F. The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. Blaschko H., Muscholl E. Handbook of Experimental Pharmacology - Catecholamines. Vol. 33:1972;283-335 Springer-Verlag, Berlin.
10. 2T receptors on human blood platelets. Br. J. Pharmacol. 108:1993;728-733.
11. 2T purinoceptor antagonist, FPL67085 in vitro and in the anaesthetized rat in vivo. Br. J. Pharmacol. 115:1995;1110-1116.
12. 2T receptors. Br. J. Pharmacol. 129:2000;275-282.
13. Jin J., Dasari V.R., Sistare F.D., Kunapuli S.P. Distribution of P2Y receptor subtypes on haematopoietic cells. Br. J. Pharmacol. 123:1998;789-794.
14. Leff P., Wood B.E., O'Connor S.E. Suramin is a slowly-equilibrating but competitive antagonist at P2X receptors in the rabbit isolated ear artery. Br. J. Pharmacol. 101:1990;645-649.
15. 1 receptor is an ADP receptor antagonised by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett. 403:1997;26-30.
16. McKechnie K.C.W., Crack B.E., Dainty I.A., Leff P. The effect of ecto-ATPase inhibition on agonist potency orders at P2Y and P2X purinoceptors. Br. J. Pharmacol. 114:(Suppl.):1995;104P.
17. 2T (adenosine diphosphate) purinergic receptors. J. Pharmacol. Exp. Ther. 261:1992;580-585.
18. Murgo A.J., Contrera J.G., Sistare F.D. Evidence for separate calcium signalling P2T and P2U receptors in human megakaryocytic Dami cells. Blood. 83:1994;1258-1267.
19. 1 receptor. Mol. Pharmacol. 54:1998;1118-1123.
20. Paton W.D.M., Rang H.P. A kinetic approach to the mechanism of drug action. Adv. Drug Res. 3:1966;57-80.
21. Pollard C.E., Roberts S.M., Mead F.C., Leff P. Are there sub-types of airway epithelial nucleotide receptor? Pediatr. Pulmonol. Suppl. 10:1994;220P.
22. Pollard C.E., Davie C.S., Roberts S.M., Alexander P.D., Springthorpe B., Mortimore M.P., Guile S.D., Leff P. Identification of an apparently novel, nucleotide-recognising receptor linked to chloride secretion in rabbit and human airway epithelium. Br. J. Pharmacol. 126:(Suppl.):1999;85P.
23. 1 purinoceptor in ADP induced platelet activation. FEBS Lett. 422:1998;291-295.
24. Todorov L.D., Mihaylova Todorova S., Westfall T.D., Sneddon P., Kennedy C., Bjur R.A., Westfall D.P. Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature. 387:1997;76-79.
25. Tomlinson W., Humphries R.G., Robertson M.J., Leff P. ARL67085 and ARL66096 are slowly dissociating competitive P2T-purinoceptor antagonists. Br. J. Pharmacol. 120:(Suppl.):1997;131P.
26. Ziganshin A.U., Hoyle C.H., Burnstock G. Ecto-enzymes and metabolism of extracellular ATP. Drug Dev. Res. 32:1994;134-146.